FLUENT Corp. (CNTMF)
OTCMKTS · Delayed Price · Currency is USD
0.0669
-0.0031 (-4.46%)
Aug 1, 2025, 2:39 PM EDT
SpringWorks Therapeutics Market Cap
FLUENT has a market cap or net worth of $28.45 million as of August 1, 2025. Its market cap has decreased by -44.13% in one year.
Market Cap
28.45M
Enterprise Value
134.76M
Revenue
105.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since March 21, 2019, FLUENT's market cap has decreased from 304.17M to 28.45M, a decrease of -90.65%. That is a compound annual growth rate of -31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 35.56M | 7.55% |
| Dec 31, 2024 | 33.06M | 22.64% |
| Dec 28, 2023 | 26.96M | -15.48% |
| Dec 30, 2022 | 31.89M | -80.90% |
| Dec 31, 2021 | 167.01M | 8.30% |
| Dec 31, 2020 | 154.21M | 74.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |